104 results on '"Lipton, Richard B."'
Search Results
2. The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders
3. Pre- and post-headache phases of migraine: multi-country results from the CaMEO – International Study
4. Real-World Use of Ubrogepant as Acute Treatment for Migraine with an Anti-Calcitonin Gene-Related Peptide Monoclonal Antibody: Results from COURAGE
5. A polygenic risk score for Alzheimer’s disease constructed using APOE-region variants has stronger association than APOE alleles with mild cognitive impairment in Hispanic/Latino adults in the U.S.
6. Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review
7. Real-world effectiveness, satisfaction, and optimization of ubrogepant for the acute treatment of migraine in combination with onabotulinumtoxinA: results from the COURAGE Study
8. Availability of healthy foods, fruit and vegetable consumption, and cognition among urban older adults
9. Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraine
10. Interaction analysis of ancestry-enriched variants with APOE-ɛ4 on MCI in the Study of Latinos-Investigation of Neurocognitive Aging
11. Medication overuse headache
12. Health State Utility Mapping of Rimegepant for the Preventive Treatment of Migraine: Double-Blind Treatment Phase and Open Label Extension (BHV3000-305)
13. Premonitory symptoms in migraine: a systematic review and meta-analysis of observational studies reporting prevalence or relative frequency
14. Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF study
15. The Association Between the Occurrence of Common Treatment-Emergent Adverse Events and Efficacy Outcomes After Lasmiditan Treatment of a Single Migraine Attack: Secondary Analyses from Four Pooled Randomized Clinical Trials
16. Lasmiditan for Patients with Migraine and Contraindications to Triptans: A Post Hoc Analysis
17. Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trials
18. Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study
19. Patient-reported outcomes, health-related quality of life, and acute medication use in patients with a ≥ 75% response to eptinezumab: subgroup pooled analysis of the PROMISE trials
20. Combining patient reported outcomes and EHR data to understand population level treatment needs: correcting for selection bias in the migraine signature study
21. Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving Rimegepant
22. A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTAN
23. Psychiatric and cognitive comorbidities of persistent post-traumatic headache attributed to mild traumatic brain injury
24. Potassium channel openers — novel triggers of aura and migraine
25. Tension-type headache
26. Underuse of Behavioral Treatments for Headache: a Narrative Review Examining Societal and Cultural Factors
27. Interrelations between migraine-like headache and persistent post-traumatic headache attributed to mild traumatic brain injury: a prospective diary study
28. Reliability and validity of the 6-item Headache Impact Test in chronic migraine from the PROMISE-2 study
29. The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine
30. Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment: A Pooled PREEMPT Analysis
31. Framing potential for adverse effects of repetitive subconcussive impacts in soccer in the context of athlete and non-athlete controls
32. Post-Traumatic Stress Disorder After Traumatic Brain Injury—A Systematic Review and Meta-Analysis
33. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study
34. Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR study
35. Longitudinal assessment of utilities in patients with migraine: an analysis of erenumab randomized controlled trials
36. DFN-02, Sumatriptan 10 mg Nasal Spray with Permeation Enhancer, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Study Assessing Functional Disability and Subject Satisfaction with Treatment
37. Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study
38. Migraine day frequency in migraine prevention: longitudinal modelling approaches
39. Effects of onabotulinumtoxinA treatment in patients with and without allodynia: results of the COMPEL study
40. Costs of Acute Headache Medication Use and Productivity Losses Among Patients with Migraine: Insights from Three Randomized Controlled Trials
41. Repeated Spiral Drawings in Essential Tremor: a Possible Limb-Based Measure of Motor Learning
42. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study
43. Gray matter volume covariance patterns associated with gait speed in older adults: a multi-cohort MRI study
44. Recalled early life adversity and pain: the role of mood, sleep, optimism, and control
45. Experts’ opinion about the pediatric secondary headaches diagnostic criteria of the ICHD-3 beta
46. Experts’ opinion about the primary headache diagnostic criteria of the ICHD-3rd edition beta in children and adolescents
47. Caffeine in the management of patients with headache
48. Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design
49. Association Between Obesity and Migraine in Women
50. Lower inhibitory control interacts with greater pain catastrophizing to predict greater pain intensity in women with migraine and overweight/obesity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.